Mechanisms and Potential Treatment Options of Heart Failure in Patients With Multiple Myeloma.

Author: JadaKeji, Kakieu DjossiSandrine, KhedrAnwar, MostafaJihan A, NeupaneBandana, ProskuriakovaEkaterina

Paper Details 
Original Abstract of the Article :
Multiple myeloma is a pathology of plasma cells, with one of the most common side effects of its treatment is heart failure. In addition, cardiac amyloidosis could cause heart failure by itself. Even though mechanisms of cardiac amyloidosis are known, and they involve lysosomal dysfunction, reactive...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312996/

データ提供:米国国立医学図書館(NLM)

Heart Failure in Multiple Myeloma: Understanding the Complexities

Multiple myeloma, a type of blood cancer, can be like a sandstorm, disrupting the delicate balance of the body's systems. This study explores the complex relationship between multiple myeloma and heart failure, a condition that weakens the heart's ability to pump blood effectively.

Unraveling the Mechanisms of Heart Failure in Multiple Myeloma

The authors delve into the various mechanisms that can lead to heart failure in patients with multiple myeloma, including treatment-related cardiotoxicity and the development of cardiac amyloidosis. It's like piecing together a desert puzzle, understanding the various factors that contribute to this challenging condition.

Exploring Potential Treatment Options

The study highlights the need for research into new treatments to protect against heart failure in multiple myeloma patients. It's like seeking out a hidden oasis in the desert, searching for new solutions to address this complex problem. The authors discuss the potential of agents like dexrazoxane, liposomal doxorubicin, and metformin, offering hope for improved patient outcomes.

Dr.Camel's Conclusion

This study sheds light on the complex relationship between multiple myeloma and heart failure, offering a comprehensive overview of the underlying mechanisms and potential treatment options. The research underscores the importance of continued exploration and innovation in this field to improve the lives of patients living with multiple myeloma.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-11-07
Further Info :

Pubmed ID

34336442

DOI: Digital Object Identifier

PMC8312996

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.